1.03
3.00%
0.03
Dopo l'orario di chiusura:
1.01
-0.02
-1.94%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Cyclacel Pharmaceuticals Inc Borsa (CYCC) Ultime notizie
Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study - ForexTV.com
Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study - StockTitan
Entero Therapeutics (NASDAQ:ENTO) Stock Quotes, Forecast and News Summary - Benzinga
(CYCCP) Trading Report - Stock Traders Daily
Cyclacel Pharmaceuticals (CYCC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN
Cyclacel Pharmaceuticals (CYCC) Price Target Increased by 11.56% to 13.94 - MSN
Cyclacel halts dividend on preferred stock - Investing.com
Cyclacel halts dividend on preferred stock By Investing.com - Investing.com Canada
Cyclacel halts dividend on preferred stock By Investing.com - Investing.com UK
Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com
Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance UK
Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter - ForexTV.com
Cyclacel Pharmaceuticals May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Benzinga
Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter - StockTitan
Cyclacel Pharmaceuticals Inc (CYCC)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Metric Analysis: Cyclacel Pharmaceuticals Inc (CYCC)’s Key Ratios in the Limelight - The Dwinnex
Cyclacel Pharmaceuticals (CYCC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Cyclacel Pharmaceuticals (CYCC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Nasdaq
You might want to take a look at Cyclacel Pharmaceuticals Inc (CYCC) now - SETE News
How To Trade (CYCCP) - Stock Traders Daily
Cyclacel Pharmaceuticals faces potential Nasdaq delisting - Investing.com India
Cyclacel Pharmaceuticals faces potential Nasdaq delisting By Investing.com - Investing.com UK
Geopark Ltd, Cyclacel Pharmaceuticals, Another 3 Companies Have A High Estimated Dividend Yield - Via News Agency
Cyclacel stock plunges to 52-week low at $1.13 amid market challenges - Investing.com
Cyclacel stock plunges to 52-week low at $1.13 amid market challenges - Investing.com Canada
Cyclacel stock plunges to 52-week low at $1.13 amid market challenges - Investing.com Australia
Cyclacel stock plunges to 52-week low at $1.13 amid market challenges - Investing.com UK
Cyclacel Pharmaceuticals faces Nasdaq delisting - Investing.com
Cyclacel Pharmaceuticals faces Nasdaq delisting By Investing.com - Investing.com UK
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q2 2024 Earnings Call Transcript - MSN
Cyclacel Pharmaceuticals changes its auditor - Investing.com
Cyclacel Pharmaceuticals changes its auditor By Investing.com - Investing.com UK
Cyclacel stock hits 52-week low at $1.21 amid market challenges - Investing.com
Cyclacel stock hits 52-week low at $1.21 amid market challenges - Investing.com UK
Cyclacel Pharmaceuticals Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St
Cyclacel Pharmaceuticals Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
CYCC’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Ratio Revelations: Cyclacel Pharmaceuticals Inc (CYCC)’s Financial Metrics in the Spotlight - The Dwinnex
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Cyclacel reports progress in fadraciclib study - Investing.com
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q2 Loss, Misses Revenue Estimates - MSN
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update - StockTitan
San Juan Basin Royalty Trust, Cyclacel Pharmaceuticals, Another 4 Companies Have A High Estimated Dividend Yield - Via News Agency
Cyclacel Pharmaceuticals (CYCC) to Release Quarterly Earnings on Wednesday - Defense World
Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results - StockTitan
Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results - Morningstar
Cyclacel Pharmaceuticals, Inc.'s (NASDAQ:CYCC) Path To Profitability - Simply Wall St
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Shares Sold by Acadian Asset Management LLC - Defense World
Cyclacel Pharmaceuticals (CYCC) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Cyclacel Pharmaceuticals, Standard Register Company, Another 3 Companies Have A High Estimated Dividend Yield - Via News Agency
(CYCCP) On The My Stocks Page - Stock Traders Daily
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Downgraded by StockNews.com to “Sell” - Defense World
Cyclacel Pharmaceuticals Inc: Rising -85.60% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions - ForexTV.com
Cyclacel Pharma Shares Rise 11% After European Patent Allowance Notice for Plogosertib - MarketWatch
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical ... - StockTitan
Cyclacel Pharmaceuticals expands equity incentive plan By Investing.com - Investing.com India
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions - StockTitan
Kernel Group Holdings amends Business Combination Agreement with AIRO Group By Investing.com - Investing.com
Cyclacel Pharmaceuticals expands equity incentive plan - Investing.com India
Citi lifts Segro stock target, maintains buy stance By Investing.com - Investing.com South Africa
Cyclacel Pharmaceuticals expands equity incentive plan By Investing.com - Investing.com Australia
Cathie Wood's ARK ETF focuses on PagerDuty, 10X Genomics stock By Investing.com - Investing.com
Cyclacel Pharmaceuticals Announces Key Corporate Decisions at 2024 Annual MeetingTipRanks.com - TipRanks
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):